Delta neutrophil index versus lactate clearance: Early markers for outcome prediction in septic shock patients  by Zanaty, Ola M. et al.
Alexandria Journal of Medicine (2012) 48, 327–333Alexandria University Faculty of Medicine
Alexandria Journal of Medicine
www.sciencedirect.comORIGINAL ARTICLEDelta neutrophil index versus lactate clearance: Early
markers for outcome prediction in septic shock patientsOla M. Zanaty a,*, Mohamed Megahed b,1, Hala Demerdash c,2, Rania Swelem d,3a Department of Anesthesia and Surgical Intensive Care, Faculty of Medicine, University of Alexandria, Egypt
b Department of Critical Care Medicine, Faculty of Medicine, University of Alexandria, Egypt
c Department of Pharmacology, Clinical Pathology unit, Faculty of Medicine, University of Alexandria, Egypt
d Department of Clinical Pathology, Faculty of Medicine, University of Alexandria, EgyptReceived 21 March 2012; accepted 23 May 2012
Available online 29 June 2012*
th
A
E
m
D
1
2
3
Pe
M
20
htKEYWORDS
Sepsis;
Septic shock;
DNI;
Lactate clearance;
MortalityCorresponding author. Per
esia and Surgical Intensive C
lexandria, Egypt. Tel.: +20 0
-mail addresses: Olazanaty@
egahed@yahoo.com (M. M
emerdash), rswelem@yahoo.
Tel.: +20 01284087878.
Tel.: +20 01229501257.
Tel.: +20 01221768210.
er review under responsibilit
edicine.
Production an
90-5068 ª 2012 Alexandria
tp://dx.doi.org/10.1016/j.ajmmanent a
are, Facu
1118444
yahoo.c
egahed),
com (R.
y of Ale
d hostin
Universit
e.2012.05Abstract Background: This study was carried out to evaluate, compare the clinical utility of delta
neutrophil index (DNI) values and lactate-6h-clearance as early indicators for outcome prediction
in septic shock patients and to ﬁnd out and correlate the speciﬁcity and sensitivity of each to the
patient’s mortality.
Methods: The study was carried out in Alexandria Main University Hospital on 53 adult patients
with severe sepsis/septic shock after taking an informed written consent and approval of the ethics
committee. All patients received all standard therapy and resuscitation measures. Arterial blood sam-
ples were obtained for measurement of DNI using an ADVIA 2120 automated cell analyzer. Initial
arterial serum lactate level and arterial lactate after 6 h from admission were measured for lactate-6h-
clearance calculation. Primary outcome measures were hospital mortality (non-survivors) and dis-
charge or transfer to a general medical ward (survivors). Data were analyzed by SPSS software using
(‘‘t’’ test and chi-square v2) P< 0.05 was considered signiﬁcant.
Results: A total of 53 severe sepsis/septic shock patients were enrolled in the study, patients were (36)
survivors and (17) non-survivors. This study demonstrated the reliability of DNI and lactate-6h-
clearance as predictors of negative outcome. Variables identiﬁed by the backward logistic regressionddress: Department of Anes-
lty of Medicine, University of
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328 O.M. Zanaty et al.model as signiﬁcantly correlated with negative outcome were lactate-6h-clearance <15%; (sensitiv-
ity, 92.5%; speciﬁcity, 85.0%; positive predictive value, 90.0%; and negative predictive value, 88.0%)
and DNI value >5.2; (sensitivity, 95.0%; speciﬁcity, 90.0%; positive predictive value, 92.0%; and
negative predictive value, 95.0%).
Conclusion: Monitoring of lactate-6h-clearance can be used to identify patients with severe sepsis/
septic shock at high risk of mortality. DNImay serve as a more useful diagnostic and prognostic mar-
ker for early diagnosis of disease severity in patients with severe sepsis/septic shock, it is suggested
that, increased DNI value should alert clinicians to apply more aggressive therapy.
ª 2012 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.1. Introduction
In spite of recent advances in antibiotic therapy and general
critical care practices, mortality of patients with severe sep-
sis/septic shock is still substantial. Many investigators have
tried to ﬁnd reliable biomarkers which are useful for the diag-
nosis and management of sepsis. Ideally, the biomarker should
reﬂect not only the presence of sepsis, but also its severity.
Although several biomarkers have been investigated, no single
biologic marker has been shown to reliably identify patient’s
outcome.1
During stress or infection, less mature neutrophil forms en-
ter circulation, including an increased number of bands. This is
referred to as a left-shift, which is deﬁned as an elevated imma-
ture/total granulocyte ratio or an elevated neutrophil band
count. Recent technological advances have led to speciﬁc mod-
ern automated cell analyzers that can provide information on
leukocyte differentials based on cytochemical myeloperoxidase
(MPO) reaction and nuclear lobularity of the white blood
cells.1 Delta neutrophil index (DNI), the difference between
the leukocyte differentials measured in the MPO channel and
those assayed in the nuclear lobularity channel, reﬂects the
fraction of circulating immature granulocytes. DNI has been
reported to be signiﬁcantly associated with mortality in pa-
tients with suspected severe sepsis/septic shock in the ICU set-
ting. The data, however, are limited and little is known about
the clinical usefulness of DNI in evaluating sepsis severity and
in assessing the risk of mortality in severe sepsis/septic shock
patients.2,3
Patients with severe sepsis/septic shock may experience
ineffective arterial circulation due to the vasodilatation associ-
ated with infection or impaired cardiac output, when oxygen
delivery fails to meet tissue oxygen demands in critical illness,
there is a compensatory increase in oxygen extraction. If the
imbalance between oxygen delivery and consumption is uncor-
rected, the compensatory response is exhausted, resulting in an
oxygen debt, global tissue hypoxia, anaerobic metabolism, and
increased lactate production. Poorly perfused tissue beds result
in global tissue hypoxia, is often found in association with an
elevated serum lactate level.4–6 Although the mechanisms are
complex, global tissue hypoxia that accompanies severe sepsis
and septic shock independently contributes to the systemic
inﬂammatory response leading to endothelial activation, vaso-
dilation, release of inﬂammatory mediators, and modulation
of the coagulation system, all resulting in the multiple organ
dysfunction syndrome and death.7–9 Numerous studies have
established the use of lactate as a diagnostic, therapeutic,
and prognostic marker of global tissue hypoxia in severe sep-
sis/septic shock patients.6 A serum lactate value greater than4 mmol/L is correlated with increased severity of illness and
poorer outcomes.10,11 The sensitivity and speciﬁcity of single
lactate concentrations as markers of tissue hypoperfusion have
been debated; however, serial measurements or lactate clear-
ance over time may be a better prognostic marker of organ
failure and patient’s mortality. A huge bulk of research has
been focused on lactate production/removal in critically ill
patients. Some evidence suggests that persistent elevation in
lactate is associated with high mortality rate. It is generally
agreed that the longer the lactate levels remain high, the worse
the prognosis.12–14
Systemic inﬂammatory response syndrome (SIRS) was
deﬁned as two or more of the following conditions:(a) body
temperature >38 C or <36 C; (b) leukocytosis (>10,000/
ll), leukopenia (<4000/ll), or >10% bands; (c) heart rate
>90 beats/min; and (d) respiratory rate >20 breaths/min or
PaCO2 < 32 mm Hg. Sepsis was deﬁned as SIRS with proven
or suspected microbial etiology. Severe sepsis was deﬁned as
sepsis plus sepsis-induced organ dysfunction or tissue hypoper-
fusion. Septic shock was deﬁned as an acute circulatory failure
characterized by persistent arterial hypotension (systolic arte-
rial pressure below 90 mm Hg, mean arterial pressure
<60 mmHg, or a reduction in systolic pressure of>40 mm Hg
from baseline despite adequate ﬂuid resuscitation in the ab-
sence of other causes of hypotension).15
This study was carried out to evaluate, compare the clinical
utility of (DNI) values and lactate-6h-clearance as early indica-
tors for outcome prediction in septic shock patients and to ﬁnd
out and correlate the speciﬁcity and sensitivity of each to the
patient’s mortality.
2. Methods
This prospective observational study was carried out in
Alexandria Main University Hospital on 53 adult patients with
severe sepsis/septic shock in the Intensive Care Unit (ICU)
after taking an informed written consent and approval of the
ethics committee. Diagnosis of sepsis was suspected in patients
with body temperature above 38,or less than 36, heart rate
more than 90 beats/min, presence of leucocytosis above
10,000/ll, positive blood culture or presence of radiological
ﬁndings indicating for pneumonia. All patients received all
standard therapy and resuscitation measures to control their
condition. Patients with Glasgow Coma Scale (GCS) 68,
patients with age <18 years, myocardial infarction, pulmon-
ary edema, hemorrhagic shock, trauma, seizure, pregnancy,
do-not-attempt-resuscitation orders, or requiring immediate
surgery were excluded from the study. All patients were evalu-
ated by the Acute Physiology and Chronic Health Evaluation
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was used to evaluate the patients during ICU stay.17
Blood samples for the analysis of DNI and other laboratory
parameters were taken within the ﬁrst 6 h of ICU admission;
blood samples for DNI were collected in EDTA tubes. All sam-
ples were immediately transported to clinical pathology labora-
tory department. Blood culture was done as a routine work in
ICU to conﬁrm the diagnosis, before the initiation of antibiotic
therapy. Determination of DNI assay was performed within 1 h
of blood sampling. A speciﬁc type of automated cell analyzer
(ADVIA 2120 Hematology System, Siemens Healthcare Diag-
nostics, Forchheim, Germany) was used for calculating DNI.
This is a ﬂow cytometry-based hematologic analyzer which
has two independent white blood cell (WBC) analysis methods,
an MPO channel and lobularity/nuclear density channel. First,
after lysis of red blood cells (RBCs), the tungsten-halogen
based optical system of the MPO channel measures cell size
by forward light scatter, and stain intensity by absorbance,
thereby counting and differentiating granulocytes, lymphocytes
and monocytes based on their size and MPO content. Second,
the laser diode-based optical system of the lobularity/nuclear
density channel counts and classiﬁes cells according to size, lob-
ularity, and nuclear density. DNI = [the neutrophil subfrac-
tion and the eosinophil subfraction measured in the MPO
channel by cytochemical MPO reaction] – [the polymorphnu-
clear leukocytes (PMN) subfraction measured in the nuclear
lobularity channel by the reﬂected light beam]. The measure-
ment of immature granulocytes included promyelocytes, myel-
ocytes, metamyelocytes and band cells, but not blasts.18
Initial arterial serum lactate level and arterial lactate after
6 h from admission were measured for lactate-6h-clearance
calculation [(lactate start – lactate 6 h · 100)/lactate start].
Samples for lactate were centrifuged at low speed (3000 rpm)
and serum was frozen at –80 C until assayed. A positive value
denotes a decrease or clearance of lactate, whereas a negative
value denotes an increase in lactate after 6 h. Lactate levels
were measured in arterial blood using point-of-care blood
gas analyzers (Critical Care Xpress, NOVA biomedical, MA,
and USA). All measurements were performed according to
the manufacturers’ instructions. Duration of the study was
21 days from the admission day. Primary outcome measures
were hospital mortality (negative outcome = non survivors)
and discharge or transfer to a general medical ward (positive
outcome = survivors).
2.1. Statistical analysis
Data were analyzed by using SPSSR software (Statistical pack-
age for social science for personal computers) using (t and chi-
square X2 tests), data were expressed as mean ± SD and P<
0.05 considered signiﬁcant.
3. Results
A total of 53 patients admitted to ICUs of Alexandria Main
University Hospital were enrolled in the study. There was no
signiﬁcant relation between the admitting diagnosis and the
patient’s outcome. The predominant admission diagnosis was
respiratory tract infection with 52.3% patients presenting in
septic shock. Intubations were performed in the ICU in
54.2% of patients and mechanical ventilation was started.Patients diagnosed as having severe sepsis/septic shock were
classiﬁed as survivors (36 patients) and non-survivors (17
patients) according to their outcome. Mean time of mortality
in non-survivors was 15.7 ± 2.4 days. There were no statisti-
cally signiﬁcant differences between the survivors and non-
survivors as regards demographic data; (age, weight, and
sex), baseline APACHE II scoring system and GCS (Table 1).
As regards blood culture, it was positive in 47.2% in survi-
vors and in 70.6% of non-survivors. A total of 5 species of
microorganisms were detected from blood specimens, such as
Staphylococcus species (n= 9), Klebsiella pneumoniae (n=
6), streptococcus species (n= 5), Escherichia coli (n= 4),
Enterococcus species (n= 4) (Table 1).
There were no statistically signiﬁcant differences between
the survivors and nonsurvivors as regards baseline HR,
MAP and temperature. Signiﬁcantly higher SOFA scores were
more frequent in non-survivors compared to survivors
(P= 0.039) (Table 2).
Hematologic and laboratory variables in relation to DNI
and lactate-6h-clearance in patients with severe sepsis/septic
shock are summarized in the Table 3, in which patients’ results
of DNI and lactate-6h-clearance exhibited signiﬁcant statistical
differences in non-survivors compared to survivors more than
other hematologic and laboratory variables. Lactate at baseline
was not different between survivors and non-survivors but lac-
tate-6h-clearance was signiﬁcantly less in non-survivor patients
compared to survivors (14.72 ± 7.11% vs 36.49 ± 12.11%,
respectively; P= 0.001). DNI showed signiﬁcantly higher val-
ues in non-survivors compared with survivors (19.0 ± 3.22%
vs 5.2 ± 1.2%, respectively; P= 0.0001) with more signiﬁcant
P value than that of lactate-6h-clearance (Table 3).
DIC incidence was signiﬁcantly higher in non-survivors
compared with survivors (58.8% vs 30.5%, respectively; P=
0.005) with signiﬁcant elevation of platelet count, prothrombin
time and D-dimer (Table 3).
The results of the present study showed that the DNI index
has implications for the prevalence of overt DIC and mortality
in patients with severe sepsis/septic shock (Table 4).
The odds ratio for impaired lactate-6h-clearance is highly
signiﬁcant for the negative outcome but DNI appears superior.
The odds ratios of selected risk factors are displayed in ROC
curves for DNI, lactate-6h-clearance and initial lactate value.
It demonstrates the reliability of DNI and lactate-6h-clearance
as predictors of negative outcome. Variables identiﬁed by the
backward logistic regression model as signiﬁcantly correlated
with negative outcome were lactate-6h-clearance <15%; (sen-
sitivity, 92.5%; speciﬁcity, 85.0%; positive predictive value,
90.0%; and negative predictive value, 88.0%) and DNI value
>5.2; (sensitivity, 95.0%; speciﬁcity, 90.0%; positive predic-
tive value, 92.0%; and negative predictive value, 95.0%)
(Table 5) (Fig. 1).
4. Discussion
The pathogenic link between global tissue hypoxia, morbidity,
and mortality in sepsis has been thoroughly documented. Lac-
tate represents a useful and clinically obtainable marker of tis-
sue hypoxia and disease severity. Among septic shock patients,
only survivors had a signiﬁcant decrease in lactate concentra-
tions over the course of the disease. In contrast, non-survivors
had signiﬁcantly higher lactate concentrations during both the
Table 1 Baseline clinical characteristics of patients by survival.
Variables Survivors (n= 36) Non-survivors (n= 17) P
Age (yr) 58.6 ± 14.5 64.4 ± 12.4 0.106
Male 25 (69.4%) 13 (76.5%)
Female 11 (30.6%) 4 (23.5%) 0.225
Weight (kg) 79.6 ± 7.25 76.5 ± 6.98 0.336
Primary site of infection:
Lung 19 (52.8%) 11 (64.7%) 0.098
Intra-abdomen 8 (22.2%) 4 (23.5%) 0.699
Genitourinary 7 (19.4%) 2 (11.8%) 0.72
Others 2 (5.6%) 0 (0%) 0.366
Positive blood culture 17 (47.2%) 12 (70.6%) 0.034*
Gram positive 6(16.7%) 4 (23.5%) 0.045*
Gram negative 9 (25.0%) 6 (35.3%) 0.041*
Fungus 2 (5.6%) 2 (11.8%) 0.075
None detected 19 (52.8%) 5 (29.4%) 0.011*
APACHE II 19.9 ± 6.8 21.6 ± 6.8 0.285
GCS 9.28 ± 2.11 10.9 ± 3.25 0.22
Table 2 Comparisons between survivors and non-survivors as regards; SOFA scores and vital signs.
Variables Survivors Non-survivors P
(n 36) (n17)
Temperature C 36.8 ± 2.6 37.6 ± 1.8 0.822
Respiratory rate (breath/min) 28.4 ± 3.1 27.6 ± 2.9 0.789
Heart rate (beats/min) 114.5 ± 24.6 116.5 ± 20.5 0.698
MAP(mm Hg) 74.1 ± 22.1 79.6 ± 23.4 0.541
SOFA score 7.9 ± 4.2 11.7 ± 4.8 0.039*
Table 3 Hematologic and laboratory variables in relation to DNI and lactate-6h-clearance in patients with severe sepsis/septic shock.
Variable Survivors Non-survivors P
(n= 36) (n= 17)
DNI% 5.2 ± 1.2 19.0 ± 3.22 0.0001*
WBC, per mm3 17.9 ± 11.6 18.7 ± 7.5 0.452
Hematocrit, % 39.0 ± 6.8 36.1 ± 7.4 0.1558
Platelet, per mm3 274,000 ± 109,000 190,000 ± 77,000 0.017*
Prothrombin time (s) 16.7 ± 3.6 20.1 ± 8.3 0.047*
Base deﬁcit (mmol/L) 7.4 ± 8.1 8.6 ± 5.8 0.107
Ph 7.32 ± 0.19 7.30 ± 0.21 0.65
DIC 11(30.5%) 10(58.8%) 0.005*
D-dimer (ng/mL) 2657 ± 1049 4163 ± 2311 0.0025*
Lactate clearance % 36.49 ± 12.11 14.72 ± 7.11 0.001*
Initial lactate, mmol/L 6.28 ± 2.18 6.01 ± 1.66 0.127
6 h Lactate, mmol/L 3.36 ± 1.15 4.97 ± 2.01 0.018*
Table 5 Sensitivity and speciﬁcity of DNI, lactate and lactate-
6h-clearance.
Sensitivity Speciﬁcity PPV NPV
DNI 95.0 90.0 92.0 95.0
Lactate-6h-clearance 92.5 85.0 90.0 88.0
Lactate 88.6 78.0 82.6 75.0
NPV: negative predictive value.
PPV: positive predictive value.
Table 4 Correlation between DNI and DIC parameters.
DNI # R P
Platelet count 0.4582 0.013*
D-dimer 0.339 0.028*
Prothrombin time (secs) 0.487 0.011*
DIC 0.399 0.0212*
R: Correlation coefﬁcient.
330 O.M. Zanaty et al.initial and ﬁnal phases of shock. The present study extends the
concept of lactate normalization during early therapeuticintervention. Our ﬁndings suggest that lactate clearance, as
deﬁned by the percentage of lactate cleared over the ﬁrst 6-h
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Figure 1 Roc curve to determine the sensitivity and speciﬁcity of
DNI, lactate and lactate-6h-clearance.
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ciated with decreased mortality rate. Patients with high lactate
clearance had decreased mortality rates. During resuscitation,
a lactate clearance of >15% from its baseline value in as brief
a period as 6 h is achievable, when this clearance occurs during
the most proximal stages of disease presentation suggests
decreased mortality rate.
In this study, a new index of DN was determined using
parameters of leukocyte subfractions that were provided by
an automated cell analyzer (ADVIA 2120). The DNI, which
reﬂects the number of granulocyte precursors in blood, was
obtained by subtracting the fraction of mature polymorphonu-
clear leukocytes from the sum of MPO-reactive cells. The re-
sults of this study showed that DNI was signiﬁcantly correlated
with SOFA score and mortality incidence, DNI values were
higher in non-survivors (patients) compared to survivors (pa-
tients), the diagnostic value of DNI for severe sepsis/septic
shock was superior to lactate, lactate clearance or other labo-
ratory markers. Our results revealed that patients with high
DNI >5.2% displayed signiﬁcant differences in PT, platelet
counts, and D-dimer, compared to those with low DNI. These
ﬁndings suggest that increased DNI may be linked to PT,
platelet counts in patients with suspected sever sepsis. These
ﬁndings suggest that careful attention should be paid not only
to overt DIC patients, but also to non-overt DIC subjects,
especially those with increased DNI. The optimal cut-off value
of DNI for predicting severe sepsis/septic shock was 5.2%.
These ﬁndings suggest the process of granular leukocyte differ-
entiation starts from immature granulocyte formation, the
change in DNI may have preceded the change in absolute
numbers of WBC or neutrophil, thus contributing to predict-
ing the development of severe sepsis/septic shock. Thus careful
attention may be required in patients with suspected infection
for possible concomitant DIC and/or severe sepsis/septic
shock if DNI value increases up to 5–6% or more.
Several studies investigated serum lactate level and its asso-
ciation with mortality in patients admitted to the emergency
department with severe sepsis.4,10,19–22 The interpretation of
single lactate measurement has several limitations, a sepsis pa-
tient with hepatic dysfunction may have a higher lactate, also
increased lactate concentration may indicate mechanisms otherthan cellular hypoxia, such as up-regulation in epinephrine-
stimulated Na/K-adenosine triphosphatase activity in skeletal
muscle and inhibition of pyruvate metabolism or an increase
in its production.5 Given these limitations, serial lactate mea-
surements may be more important as an outcome prognostic
indicator than a single lactate measurement.23
Bakker et al.24 deﬁned ‘‘lactime’’ as the time during which
lactate remains >2 mmol/L and observed that this duration
of lactic acidosis was predictive of organ failure and survival.
Persistent lactate elevation >6 h is associated with increased
mortality rate.5 The present study extends the concept of lac-
tate normalization during early therapeutic intervention. Our
ﬁndings suggest that lactate clearance, as deﬁned by the per-
centage of lactate cleared over the ﬁrst 6-h period of disease
presentation, is an independent variable associated with de-
creased mortality rate.
Nguyen et al.5 concluded that, higher Lactate clearance in
the most proximal presentation of severe sepsis and septic
shock is associated with improved morbidity and mortality
rates, which is consistent with current efforts that emphasize
the importance of identifying and treating tissue hypoperfu-
sion during the ﬁrst 6 h of resuscitation.5
Sean et al.25 concluded that, the systematic monitoring of
lactate clearance at 2 h should be clinically useful in cases of
acute cardiac or respiratory insufﬁciency to identify patients
at high risk of negative outcome and, potentially, to increase
the intensity of the therapeutic approach and ﬁnally suggested
that, a 2-h lactate clearance >15% is highly predictive of po-
sitive outcome and may reassure clinicians that the therapeutic
approach is appropriate.
Nguyen et al.26 studied 6 h lactate clearance as a surrogate
for the resolution of global tissue hypoxia in sepsis, there was a
signiﬁcant decreased in-hospital, 28-day, and 60-day mortality
in the higher lactate clearance quartiles (P< 0.01), It was sig-
niﬁcantly associated with decreased levels of biomarkers,
improvement in organ dysfunction and outcome in severe sep-
sis and septic shock.
Otero et al.27 compared early lactate clearance with serum
biomarkers for outcome prediction in septic shock, there was
a statistically signiﬁcant inverse relationship between patients’
lactate clearance and the mean levels of each biomarker (TNF-
a, IL-1 receptor antagonist and caspase-3) over the ﬁrst 72 h of
hospitalization (P < 0.035). There was also statistically signif-
icantly higher hospital 28-day and 60-day mortality with
decreasing lactate clearance (P < 0.010).
Similar to the results of the present study, Park et al.1 study
demonstrated that DNI, which reﬂects the proportion of
immature granulocytes in circulating blood, correlates with
disease severity of sepsis in critically ill patients admitted to
the medical ICU. For assessing the risk of mortality in severe
sepsis/septic shock, DNI may be a better predictive marker
than lactate and other leukocyte derived parameters. DNI ele-
vation had 81.3% sensitivity, 91% speciﬁcity, 88.6% +ve pre-
dictive value and 84.7% ve predictive value for outcome
prediction, while lactate level elevation had 76.7% sensitivity,
57.1% speciﬁcity, 61.1 +ve predictive value and 73.7% as a
ve predictive value.
Nahm et al.2 investigated the relationship between calcu-
lated immature granulocyte (IG) counts and the severity of sep-
sis. DNI was strongly correlated with manual IG counts
(r= 0.75, P< 0.05). The mortality rate of patients with DNI
>40% markedly exceeded the mortality rate of patients with
332 O.M. Zanaty et al.DNI of 5–10% (79% versus 15%, P< 0.05).Their study dem-
onstrated a signiﬁcant relationship between DNI and DIC-re-
lated parameters, including platelet count, PT, PTT, and
antithrombin, these ﬁndings suggest that DNI may be linked
to a hypercoagulable state which is associated with sepsis. Thus
they concluded that, DNI has implications for the severity of
sepsis and may be valuable to assess the prognosis of patients
with suspected sepsis, although the estimation of DNI is limited
to the users of one type of cell analyzer.
Kim et al.28 evaluated the clinical signiﬁcance of DNI in sep-
sis. DNI values in bacteremic patients were signiﬁcantly higher
in non-survivor (n= 7) than survivor (n= 38) (14.2 ± 12.1%
versus 6.7 ± 7.5%, P= 0.03), which indicate that DNI may be
useful prognostic marker of bacteremic sepsis.
Lee et al.29 studied the usefulness of DNI as a prognostic
marker of sepsis, higher DNI values than that of the present
study were observed, patients with DNI >20% showed higher
mortality compared to those with DNI <20% (90% versus
33% P= 0.001), 90%+ve predictive value and 67% ve pre-
dictive value for mortality.
Seok et al.30 studied the role of DNI in differential diagno-
sis and prognosis prediction of patients with sepsis. The best
cut-off value for DN for predicting sepsis was 2.7%. DNI
was signiﬁcantly higher in those who died than in the survivors
and was identiﬁed to be an independent predictor for 28-day
mortality in patients with sepsis .They concluded that, DNI
may serve as a facile and useful marker for early diagnosis
and prognostic assessment of patients with sepsis.
Hye et al.31 investigated DNI as a prognostic marker in pa-
tients with bacteremia. The DNI was measured at the onset of
bacteremia, at 24 and 72 h later. A total of 102 patients were
included in the analysis, and 24 patients died within 28 days.
DNI at 72 h after the onset of bacteremia and platelet count
at the onset of bacteremia were signiﬁcantly associated with
survival and may be valuable to assess the prognosis of pa-
tients with bacteremia.
5. Conclusion
Monitoring of lactate clearance at 6 h can be used to identify
critically ill patients with severe sepsis at high risk of mortality.
DNI may serve as a more useful diagnostic and prognostic
marker for early diagnosis of disease severity in patients with
severe sepsis. High levels of DNI may help to identify patients
with an impending risk of mortality, it is suggested that, the
ﬁnding of an increased DNI value should alert clinicians to ap-
ply more aggressive therapy.
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